[PDF][PDF] Emerging immunotherapy for HCC: A guide for hepatologists
HCC is one of the most common cancers worldwide, and the third leading cause of cancer‐
related death globally. HCC comprises nearly 90% of all cases of primary liver cancer …
related death globally. HCC comprises nearly 90% of all cases of primary liver cancer …
Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance
This AASLD 2018 Hepatitis B Guidance is intended to complement the AASLD 2016
Practice Guidelines for Treatment of Chronic Hepatitis B (1) and update the previous …
Practice Guidelines for Treatment of Chronic Hepatitis B (1) and update the previous …
Trends and strategies to combat viral infections: A review on FDA approved antiviral drugs
DR Tompa, A Immanuel, S Srikanth… - International journal of …, 2021 - Elsevier
The infectious microscopic viruses invade living cells to reproduce themselves, and causes
chronic infections such as HIV/AIDS, hepatitis B and C, flu, etc. in humans which may lead to …
chronic infections such as HIV/AIDS, hepatitis B and C, flu, etc. in humans which may lead to …
Chronic hepatitis B infection: a review
LSY Tang, E Covert, E Wilson, S Kottilil - Jama, 2018 - jamanetwork.com
Importance More than 240 million individuals worldwide are infected with chronic hepatitis B
virus (HBV). Among individuals with chronic HBV infection who are untreated, 15% to 40 …
virus (HBV). Among individuals with chronic HBV infection who are untreated, 15% to 40 …
Approved antiviral drugs over the past 50 years
E De Clercq, G Li - Clinical microbiology reviews, 2016 - Am Soc Microbiol
Since the first antiviral drug, idoxuridine, was approved in 1963, 90 antiviral drugs
categorized into 13 functional groups have been formally approved for the treatment of the …
categorized into 13 functional groups have been formally approved for the treatment of the …
[PDF][PDF] A ASLD guidelines for treatment of chronic hepatitis B
NA Terrault, NH Bzowej, KM Chang, JP Hwang… - …, 2016 - Wiley Online Library
A<fc>ASLD</fc> guidelines for treatment of chronic hepatitis <fc>B</fc> Page 1 PRACTICE
GUIDELINE AASLD Guidelines for Treatment of Chronic Hepatitis B Norah A. Terrault,1 Natalie …
GUIDELINE AASLD Guidelines for Treatment of Chronic Hepatitis B Norah A. Terrault,1 Natalie …
Tenofovir alafenamide versus tenofovir disoproxil fumarate for the treatment of patients with HBeAg-negative chronic hepatitis B virus infection: a randomised, double …
Background The novel prodrug tenofovir alafenamide delivers the nucleotide reverse
transcriptase inhibitor tenofovir to target cells more efficiently at a lower dose than tenofovir …
transcriptase inhibitor tenofovir to target cells more efficiently at a lower dose than tenofovir …
[PDF][PDF] Antiviral therapy for chronic hepatitis B viral infection in adults: a systematic review and meta‐analysis
ASF Lok, BJ McMahon, RS Brown Jr, JB Wong… - …, 2016 - Wiley Online Library
Chronic hepatitis B viral (HBV) infection remains a significant global health problem.
Evidence‐based guidelines are needed to help providers determine when treatment should …
Evidence‐based guidelines are needed to help providers determine when treatment should …
[HTML][HTML] EASL clinical practice guidelines: management of chronic hepatitis B virus infection
European Association For The Study Of The Liver - Journal of hepatology, 2012 - Elsevier
Our understanding of the natural history of hepatitis B virus (HBV) infection and the potential
for therapy of the resultant disease is continuously improving. New data have become …
for therapy of the resultant disease is continuously improving. New data have become …